Evidence map›Paper›PMID 34682462›Full record

ArticleInternational journal of environmental research and public health2021

Acceptability of Clinical Trials on COVID-19 during Pregnancy among Pregnant Women and Healthcare Providers: A Qualitative Study.

Elena Marbán-Castro, Clara Pons-Duran, Laura García-Otero, Haily Chen, Luis Bernardo Herrera, María Del Mar Gil, Anna Goncé, Elena Ferriols-Pérez, Miguel Ángel Rodríguez, Paloma Toro and 4 more

Abstract read
In one paragraph

Article in International journal of environmental research and public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Elena Marbán-CastroISGlobal, Hospital Clínic-Universitat de Barcelona, 08036 Barcelona, Spain.ORCID 0000-0002-9715-0595
Clara Pons-DuranISGlobal, Hospital Clínic-Universitat de Barcelona, 08036 Barcelona, Spain.ORCID 0000-0002-9840-7559
Laura García-OteroISGlobal, Hospital Clínic-Universitat de Barcelona, 08036 Barcelona, Spain.
Haily ChenISGlobal, Hospital Clínic-Universitat de Barcelona, 08036 Barcelona, Spain.
Luis Bernardo HerreraISGlobal, Hospital Clínic-Universitat de Barcelona, 08036 Barcelona, Spain.
María Del Mar GilObstetrics and Gynecology Department, Hospital Universitario de Torrejón, Torrejón de Ardoz, 28850 Madrid, Spain.ORCID 0000-0002-9993-5249
Anna GoncéFetal Medicine Research Center, BCNatal-Barcelona Center for Maternal-Fetal and Neonatal Medicine (Hospital Clínic and Hospital Sant Joan de Déu) and Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036 Barcelona, Spain.
Elena Ferriols-PérezDepartment Gynaecology and Obstetrics, Parc de Salut Mar University Hospital, 08003 Barcelona, Spain.ORCID 0000-0002-8003-0335
Miguel Ángel RodríguezHM Puerta del Sur, Móstoles, 28938 Madrid, Spain.ORCID 0000-0002-2936-9341
Paloma ToroObstetrics and Gynecology Department, Complejo Asistencial de Segovia, Hospital General de Segovia, 40002 Segovia, Spain.
Azucena BardajíISGlobal, Hospital Clínic-Universitat de Barcelona, 08036 Barcelona, Spain.ORCID 0000-0002-5135-0540
Raquel GonzálezISGlobal, Hospital Clínic-Universitat de Barcelona, 08036 Barcelona, Spain.
Clara MenéndezISGlobal, Hospital Clínic-Universitat de Barcelona, 08036 Barcelona, Spain.
Cristina Enguita-FernàndezISGlobal, Hospital Clínic-Universitat de Barcelona, 08036 Barcelona, Spain.ORCID 0000-0003-4945-2094

Funding

Instituto de Salud Carlos III COV20/00286"la Caixa" Foundation LCF/BQ/ES17/11600006Ministerio de Ciencia e Innovación RYC-2013-14512
6 · The paper itself

Abstract

Participation of pregnant women in clinical trials entails challenges mainly related to concerns about the risks for fetuses. We undertook a qualitative study from June to October 2020 to assess the acceptability of participating in COVID-19 clinical trials among pregnant women in Spain. Phenomenology and grounded theory were used as methodological approaches. Semi-structured interviews were conducted with 24 pregnant women and six healthcare providers. Women were unsure if pregnancy was a risk factor to acquire the infection or to develop severe disease and expressed the limited information they had received, which led to uncertainties and emotional suffering. They had concerns regarding participation in clinical trials on COVID-19, regardless of the drug under study. Healthcare providers alluded to the importance of involving pregnant women's relatives at the recruitment visit of the clinical trial. These findings may be useful to facilitate pregnant women's participation in clinical trials.

Indexed as

COVID-19Pregnant PeopleClinical Trials as TopicFemaleHealth PersonnelHumansPatient ParticipationPregnancyQualitative ResearchSARS-CoV-2acceptabilityclinical trialCOVID-19healthcare professionalsperceptionspregnancy

Identifiers

PMID34682462
PMCPMC8535397

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.